Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-054626

President and CEO sold 3,606 shares at $0.92 ($3,319)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-06 Sale : show line 1 in the form −3,606 $0.92 $3,319 791,201 D
Open-market sales · 3,606 sh · avg $0.92 · $3,319
Loading xslF345X05/doc4.xml…